These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12472280)

  • 1. Proteomic evaluation of archival cytologic material using SELDI affinity mass spectrometry: potential for diagnostic applications.
    Fetsch PA; Simone NL; Bryant-Greenwood PK; Marincola FM; Filie AC; Petricoin EF; Liotta LA; Abati A
    Am J Clin Pathol; 2002 Dec; 118(6):870-6. PubMed ID: 12472280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-needle aspiration in PreservCyt: a novel and reproducible method for possible ancillary proteomic pattern expression of breast neoplasms by SELDI-TOF.
    Fowler LJ; Lovell MO; Izbicka E
    Mod Pathol; 2004 Aug; 17(8):1012-20. PubMed ID: 15195106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytologic findings and protein expression profiles associated with ductal carcinoma of the breast in ductal lavage specimens using surface-enhanced laser desorption and ionization-time of flight mass spectrometry.
    Mendrinos S; Nolen JD; Styblo T; Carlson G; Pohl J; Lewis M; Ritchie J
    Cancer; 2005 Jun; 105(3):178-83. PubMed ID: 15822128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers.
    Soltys SG; Le QT; Shi G; Tibshirani R; Giaccia AJ; Koong AC
    Clin Cancer Res; 2004 Jul; 10(14):4806-12. PubMed ID: 15269156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of surface-enhanced laser desorption/ionization -time of flight to explore bacterial proteomes.
    Barzaghi D; Isbister JD; Lauer KP; Born TL
    Proteomics; 2004 Sep; 4(9):2624-8. PubMed ID: 15352237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS): a new proteomic urinary test for patients with urolithiasis.
    Cadieux PA; Beiko DT; Watterson JD; Burton JP; Howard JC; Knudsen BE; Gan BS; McCormick JK; Chambers AF; Denstedt JD; Reid G
    J Clin Lab Anal; 2004; 18(3):170-5. PubMed ID: 15103681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) in orthodontic treatment: first pilot study.
    Ciavarella D; Mastrovincenzo M; D'Onofrio V; Chimenti C; Parziale V; Barbato E; Lo Muzio L
    Prog Orthod; 2011 Nov; 12(2):126-31. PubMed ID: 22074837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkers.
    Rai AJ; Stemmer PM; Zhang Z; Adam BL; Morgan WT; Caffrey RE; Podust VN; Patel M; Lim LY; Shipulina NV; Chan DW; Semmes OJ; Leung HC
    Proteomics; 2005 Aug; 5(13):3467-74. PubMed ID: 16052624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Profiles of low-molecular proteome spectrum obtained through SELDI-TOF mass spectrometry in the sera of patients with metastatic malignant melanoma: pilot study].
    Lakomý R'; Greplová K; Pilný R; Budinská E; Valík D; Poprach A; Nemecek R; Vyzula R
    Klin Onkol; 2009; 22(5):228-32. PubMed ID: 19886361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).
    Hong H; Dragan Y; Epstein J; Teitel C; Chen B; Xie Q; Fang H; Shi L; Perkins R; Tong W
    BMC Bioinformatics; 2005 Jul; 6 Suppl 2(Suppl 2):S5. PubMed ID: 16026602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of archival breast cancer serum.
    Zeidan BA; Cutress RI; Murray N; Coulton GR; Hastie C; Packham G; Townsend PA
    Cancer Genomics Proteomics; 2009; 6(3):141-7. PubMed ID: 19487543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment of protein fingerprint database of Salmonella paratyphi A using SELDI-TOF-MS].
    Li XQ; Huang WF; Liu H; Yang YC; Xiao DW; Yan H; Luo CL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jun; 28(6):576-9. PubMed ID: 22691346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
    Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractional factorial design for optimization of the SELDI protocol for human adipose tissue culture media.
    Szalowska E; van Hijum SA; Roelofsen H; Hoek A; Vonk RJ; te Meerman GJ
    Biotechnol Prog; 2007; 23(1):217-24. PubMed ID: 17269691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.
    Semmes OJ; Feng Z; Adam BL; Banez LL; Bigbee WL; Campos D; Cazares LH; Chan DW; Grizzle WE; Izbicka E; Kagan J; Malik G; McLerran D; Moul JW; Partin A; Prasanna P; Rosenzweig J; Sokoll LJ; Srivastava S; Srivastava S; Thompson I; Welsh MJ; White N; Winget M; Yasui Y; Zhang Z; Zhu L
    Clin Chem; 2005 Jan; 51(1):102-12. PubMed ID: 15613711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS.
    Hegmans JP; Veltman JD; Fung ET; Verch T; Glover C; Zhang F; Allard WJ; T'Jampens D; Hoogsteden HC; Lambrecht BN; Aerts J
    Technol Cancer Res Treat; 2009 Oct; 8(5):323-32. PubMed ID: 19754208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic evaluation of urine from renal cell carcinoma using SELDI-TOF-MS and tree analysis pattern.
    Wu DL; Zhang WH; Wang WJ; Jing SB; Xu YM
    Technol Cancer Res Treat; 2008 Jun; 7(3):155-60. PubMed ID: 18473487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal.
    Geng T; Seitz PK; Thomas ML; Xu B; Soman KV; Kurosky A; Luxon BA; Cunningham KA
    J Neurosci Methods; 2006 Nov; 158(1):1-12. PubMed ID: 16766040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum diagnosis of head and neck squamous cell carcinoma using surface-enhanced desorption ionization mass spectrometry and artificial neural network analyses].
    Cao SM; Guo X; Chen FJ; Yang AK; Chen WK; Li NW
    Ai Zheng; 2007 Jul; 26(7):767-70. PubMed ID: 17626756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.